150 related articles for article (PubMed ID: 32488399)
1. Incidence of unexpected uterine malignancies after electromechanical power morcellation: a retrospective multicenter analysis in Germany.
Gitas G; Alkatout I; Mettler L; Abdusattarova K; Ertan AK; Rody A; Pados G; Baum S
Arch Gynecol Obstet; 2020 Aug; 302(2):447-453. PubMed ID: 32488399
[TBL] [Abstract][Full Text] [Related]
2. Severe direct and indirect complications of morcellation after hysterectomy or myomectomy.
Gitas G; Alkatout I; Allahqoli L; Rody A; Ertan AK; Grimbizis G; Baum S
Minim Invasive Ther Allied Technol; 2022 Mar; 31(3):418-425. PubMed ID: 32762476
[TBL] [Abstract][Full Text] [Related]
3. Association Between Power Morcellation and Mortality in Women With Unexpected Uterine Cancer Undergoing Hysterectomy or Myomectomy.
Xu X; Lin H; Wright JD; Gross CP; Boscoe FP; Hutchison LM; Schwartz PE; Desai VB
J Clin Oncol; 2019 Dec; 37(35):3412-3424. PubMed ID: 31518176
[TBL] [Abstract][Full Text] [Related]
4. Morcellation and the Incidence of Occult Uterine Malignancy: A Dual-Institution Review.
Picerno TM; Wasson MN; Gonzalez Rios AR; Zuber MJ; Taylor NP; Hoffman MK; Borowsky ME
Int J Gynecol Cancer; 2016 Jan; 26(1):149-55. PubMed ID: 26332395
[TBL] [Abstract][Full Text] [Related]
5. Unexpected uterine sarcomas in 4478 patients with electric power morcellation for leiomyomas.
Chen Q; Shi H; Lu W; Lu B
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():85-89. PubMed ID: 30245442
[TBL] [Abstract][Full Text] [Related]
6. Clinical Characteristics and Prognosis of Unexpected Uterine Sarcoma After Hysterectomy for Presumed Myoma With and Without Transvaginal Scalpel Morcellation.
Zhang J; Li T; Zhang J; Zhu L; Lang J; Leng J
Int J Gynecol Cancer; 2016 Mar; 26(3):456-63. PubMed ID: 26807642
[TBL] [Abstract][Full Text] [Related]
7. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
[TBL] [Abstract][Full Text] [Related]
8. The incidence of occult malignancy following uterine morcellation: A ten-year single institution experience retrospective cohort study.
Mori KM; Abaid LN; Mendivil AA; Brown JV; Beck TL; Micha JP; Epstein HD; Goldstein BH
Int J Surg; 2018 May; 53():239-242. PubMed ID: 29621658
[TBL] [Abstract][Full Text] [Related]
9. Power morcellation for women undergoing laparoscopic supracervical hysterectomy - safety of procedure and clinical experience from 426 cases.
Rechberger T; Miotła P; Futyma K; Ziętek A; Filipczak A; Rechberger E; Szumiło J; Adamiak-Godlewska A
Ginekol Pol; 2016; 87(8):546-51. PubMed ID: 27629127
[TBL] [Abstract][Full Text] [Related]
10. Malignancy rate of 10,731 uteri morcellated during laparoscopic supracervical hysterectomy (LASH).
Bojahr B; De Wilde RL; Tchartchian G
Arch Gynecol Obstet; 2015 Sep; 292(3):665-72. PubMed ID: 25820974
[TBL] [Abstract][Full Text] [Related]
11. Incidence of Occult Uterine Malignancy Following Vaginal Hysterectomy With Morcellation.
Wasson M; Magtibay P; Magtibay P; Magrina J
J Minim Invasive Gynecol; 2017; 24(4):665-669. PubMed ID: 28254678
[TBL] [Abstract][Full Text] [Related]
12. Sarcoma Risk in Uterine Surgery in a Tertiary University Hospital in Germany.
Kundu S; Zachen M; Hertel H; Hillemanns P; Soergel P
Int J Gynecol Cancer; 2017 Jun; 27(5):961-966. PubMed ID: 28498262
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and management experience of unexpected uterine sarcoma after myomectomy.
Zhang J; Zhang J; Dai Y; Zhu L; Lang J; Leng J
Int J Gynaecol Obstet; 2015 Aug; 130(2):195-9. PubMed ID: 26117552
[TBL] [Abstract][Full Text] [Related]
14. Complication rate of uterine morcellation in laparoscopic supracervical hysterectomy: a retrospective cohort study.
Smits RM; De Kruif JH; Van Heteren CF
Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():179-82. PubMed ID: 26943477
[TBL] [Abstract][Full Text] [Related]
15. Morcellation of occult uterine malignancies: an Australian single institution retrospective study.
Tan A; Salfinger S; Tan J; Cohen P
Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):503-6. PubMed ID: 26314239
[TBL] [Abstract][Full Text] [Related]
16. Uterine sarcomas and parasitic myomas after laparoscopic hysterectomy with power morcellation.
Tan-Kim J; Hartzell KA; Reinsch CS; O'Day CH; Kennedy JS; Menefee SA; Harrison TA
Am J Obstet Gynecol; 2015 May; 212(5):594.e1-10. PubMed ID: 25499259
[TBL] [Abstract][Full Text] [Related]
17. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
Lieng M; Berner E; Busund B
J Minim Invasive Gynecol; 2015; 22(3):410-4. PubMed ID: 25460521
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of myomatous tissue extraction in laparoscopic surgery by contained in - bag morcellation: A retrospective single arm study.
Devassy R; Cezar C; Krentel H; Verhoeven HC; Devassy R; de Wilde MS; Torres-de la Roche LA; de Wilde RL
Int J Surg; 2019 Feb; 62():22-27. PubMed ID: 30639472
[TBL] [Abstract][Full Text] [Related]
19. A Multicentre Retrospective Review of Clinical Characteristics of Uterine Sarcoma.
Wais M; Tepperman E; Bernardini MQ; Gien LT; Jimenez W; Murji A
J Obstet Gynaecol Can; 2017 Aug; 39(8):652-658. PubMed ID: 28729098
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic Power Morcellation: Techniques to Avoid Tumoral Spread.
Zapardiel I; Boria F; Halaska MJ; De Santiago J
J Minim Invasive Gynecol; 2021 Aug; 28(8):1442-1443. PubMed ID: 32961359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
